Laboratory Evaluation for Hyperbilirubinemia
Initial laboratory testing for hyperbilirubinemia should include fractionated bilirubin levels, complete blood count with differential and peripheral smear, liver function tests (ALT, AST, alkaline phosphatase, γ-glutamyltransferase), albumin, total protein, and prothrombin time/INR. 1
Initial Assessment
- Determine if hyperbilirubinemia is predominantly unconjugated (<20-30% conjugated bilirubin) or predominantly conjugated (>35% conjugated bilirubin) 1
- Measure total and direct (conjugated) bilirubin to differentiate between types of hyperbilirubinemia
- Interpret bilirubin levels according to patient age (especially important in neonates) 2
Laboratory Testing Algorithm
Step 1: Core Laboratory Panel
- Fractionated bilirubin (total and direct/conjugated)
- Complete blood count with differential and peripheral smear
- Liver function tests:
- ALT (alanine transaminase)
- AST (aspartate transaminase)
- Alkaline phosphatase
- γ-glutamyltransferase (GGT)
- Albumin and total protein
- Prothrombin time/INR 1, 3
Step 2: Additional Testing Based on Bilirubin Pattern
For Predominantly Unconjugated Hyperbilirubinemia:
- Reticulocyte count
- Peripheral blood smear examination
- Glucose-6-phosphate dehydrogenase (G6PD) testing
- Blood type and Coombs' test (especially in neonates) 2
For Predominantly Conjugated Hyperbilirubinemia:
- Urinalysis and urine culture
- Evaluation for sepsis if clinically indicated
- Abdominal ultrasound (first-line imaging) 1, 3
Step 3: Specialized Testing Based on Clinical Suspicion
For suspected autoimmune liver disease:
- Anti-mitochondrial antibody (AMA)
- Anti-nuclear antibody (ANA)
- Immunoglobulin levels 1
For suspected biliary obstruction:
For neonates with prolonged jaundice (>3 weeks):
- Thyroid function tests
- Galactosemia screening 2
Special Considerations
For Rapidly Rising Bilirubin Levels
If bilirubin is rising rapidly (crossing percentiles) or not explained by history and physical examination:
- Blood type and Coombs' test (if not already obtained)
- Complete blood count and smear
- Direct/conjugated bilirubin measurement
- Consider reticulocyte count and G6PD testing 2
For Severe Hyperbilirubinemia
If bilirubin levels are approaching exchange transfusion levels or not responding to phototherapy:
- Reticulocyte count
- G6PD testing
- Albumin level 2
For Elevated Direct/Conjugated Bilirubin
- Urinalysis and urine culture
- Evaluate for sepsis if clinically indicated 2
Monitoring Recommendations
- For mild elevations (<2× ULN) with no other abnormalities: repeat testing in 2-4 weeks
- For moderate elevations (2-5× ULN): accelerated monitoring and complete diagnostic workup
- For severe elevations (>5× ULN): urgent diagnostic workup and consider hospitalization 1
- Monitor liver enzymes and function tests daily until improvement begins, then every 3-7 days until normalization 1
Common Pitfalls to Avoid
- Do not rely on visual estimation of jaundice alone, as this can lead to errors, particularly in darkly pigmented patients 2
- Do not assume normal aminotransferases rule out significant liver disease 1
- Be aware that overlooking malignancy as a cause of isolated elevated alkaline phosphatase is a significant pitfall 1
- Consider medication-induced bilirubin elevations to avoid delayed diagnosis or inappropriate management 1
By following this structured approach to laboratory evaluation of hyperbilirubinemia, clinicians can efficiently identify the underlying cause and initiate appropriate management to reduce morbidity and mortality associated with liver disease.